Gene Therapy Beneficial for Patients With Hemophilia B

FRIDAY, March 3, 2023 -- For patients with hemophilia B, one infusion of adeno-associated virus 5 (AAV5) vector expressing the Padua factor IX variant (etranacogene dezaparvovec) is noninferior and superior to prophylaxis with factor IX, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news